Effects of Breathing Exercises on Women With Primary Dysmenorhea
Launched by ANKARA YILDIRIM BEYAZIT UNIVERSITY · Mar 13, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how breathing exercises might help women who experience primary dysmenorrhea, which is a condition causing severe menstrual pain. The study aims to see if these exercises can reduce pain and improve comfort during menstruation.
To be eligible for the trial, women must be between the ages of 18 and 40, have experienced moderate to severe menstrual pain for the last six months, and have regular menstrual cycles. However, women who are pregnant, using certain medications like birth control or antidepressants, or have specific health conditions will not be able to participate. If you join the study, you can expect to learn breathing techniques that may help manage your pain. It's important to know that this trial is not yet recruiting participants, so you'll need to wait for it to begin if you're interested.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Having PD symptoms according to the Primary Dysmenorrhea Consensus criteria,
- • Having menstrual pain intensity of 4 or higher according to the Visual Analog Scale in the last 6 months,
- • Having a regular menstrual cycle (28±7 days)
- • Volunteering to participate in the study.
- Exclusion Criteria:
- • Being pregnant or suspected of pregnancy,
- • Using oral contraceptives or antidepressants in the last 6 months,
- • Using intrauterine devices,
- • Having a history of other gynecological diseases
- • Having pulmonary, neurological and/or systemic disease,
- • Having undergone abdominal or cardiothoracic surgery within the last year.
About Ankara Yildirim Beyazıt University
Ankara Yıldırım Beyazıt University is a leading academic institution in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its expertise in healthcare and innovative research methodologies to conduct ethical and scientifically rigorous clinical studies. By fostering collaboration among multidisciplinary teams, Ankara Yıldırım Beyazıt University aims to contribute to the development of novel therapies and enhance patient care, while adhering to the highest standards of regulatory compliance and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Seyda Toprak Celenay
Principal Investigator
Ankara Yildirim Beyazıt University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported